Anticoagulation Changes Following Major and Clinically Relevant Nonmajor Bleeding Events in Non-valvular Atrial Fibrillation Patients.
Thane FeldeisenConstantina Alexandris-SouphisBrian HaymartXiaowen KongEva Kline-RogersFaheem HandooKaatz ScottMona A AliJay KozlowskiVinay ShahGregory KrolJames B FroehlichGeoffrey D BarnesPublished in: Journal of pharmacy practice (2021)
Following a bleeding event, most patients restarted anticoagulation therapy, most often with the same type of anticoagulant that they previously had been taking.